Compile Data Set for Download or QSAR
maximum 50k data
Found 125 with Last Name = 'breault' and Initial = 'ga'
TargetCyclin-dependent kinase 2/G1/S-specific cyclin-E1(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM7647(4-[(4-{2-methylimidazo[1,2-a]pyridin-3-yl}pyrimidi...)
Affinity DataIC50: <3nMpH: 7.0 T: 2°CAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase 2/G1/S-specific cyclin-E1(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM7649(2,4-bisanilinopyrimidine deriv. 9 | 4-({4-[(2-fluo...)
Affinity DataIC50:  6nMpH: 7.0 T: 2°CAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM7628(2,4-bis anilino pyrimidine deriv. 24 | 5-bromo-2-N...)
Affinity DataIC50:  10nMAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase 2/G1/S-specific cyclin-E1(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM7646(CHEMBL102926 | Imidazo[1,2-a]pyridine deriv. 6 | N...)
Affinity DataIC50:  32nMpH: 7.0 T: 2°CAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
TargetCyclin-dependent kinase 2/G1/S-specific cyclin-E1(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM7645(4-{2-methylimidazo[1,2-a]pyridin-3-yl}-N-phenylpyr...)
Affinity DataIC50:  36nMpH: 7.0 T: 2°CAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM7600(2-[(2,5-dichlorophenyl)[6-({4-[3-(dimethylamino)-2...)
Affinity DataIC50:  50nMpH: 7.0 T: 2°CAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM7627(2,4-bis anilino pyrimidine deriv. 23 | 5-bromo-2-N...)
Affinity DataIC50:  100nMAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM7619(2,4-bis anilino pyrimidine deriv. 15 | 2-[(2,5-dic...)
Affinity DataIC50:  100nMAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM7604(2-[(2-bromo-4-methylphenyl)[6-({4-[3-(dimethylamin...)
Affinity DataIC50:  100nMpH: 7.0 T: 2°CAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sidPDB
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM7626(2,4-bis anilino pyrimidine deriv. 22 | 5-chloro-2-...)
Affinity DataIC50:  100nMAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM7646(CHEMBL102926 | Imidazo[1,2-a]pyridine deriv. 6 | N...)
Affinity DataIC50:  150nMpH: 7.0 T: 2°CAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase 2/G1/S-specific cyclin-E1(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM7628(2,4-bis anilino pyrimidine deriv. 24 | 5-bromo-2-N...)
Affinity DataIC50:  200nMAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM7623(2,4-bis anilino pyrimidine deriv. 19 | 4-N-(2,5-di...)
Affinity DataIC50:  200nMAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM7620(2,4-bis anilino pyrimidine deriv. 16 | 4-N-(2,5-di...)
Affinity DataIC50:  200nMAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase 2/G1/S-specific cyclin-E1(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM7627(2,4-bis anilino pyrimidine deriv. 23 | 5-bromo-2-N...)
Affinity DataIC50:  300nMAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM7625(2,4-bis anilino pyrimidine deriv. 21 | 2-N-{4-[3-(...)
Affinity DataIC50:  300nMAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM7621(2,4-bis anilino pyrimidine deriv. 17 | 3-[(2,5-dic...)
Affinity DataIC50:  300nMAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase 2/G1/S-specific cyclin-E1(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM7626(2,4-bis anilino pyrimidine deriv. 22 | 5-chloro-2-...)
Affinity DataIC50:  500nMAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM7601(3-[(2,5-dichlorophenyl)[6-({4-[3-(dimethylamino)-2...)
Affinity DataIC50:  500nMpH: 7.0 T: 2°CAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM7618(2,4-bis anilino pyrimidine deriv. 14 | 2-N-{4-[3-(...)
Affinity DataIC50:  600nMAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate racemase(Enterococcus faecalis)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50245790(4-amino-2-(butylthio)-8-(3,4-dichlorobenzyl)pterid...)
Affinity DataIC50:  650nMpH: 8.0Assay Description:Inhibition of Enterococcus faecalis murI assessed as effect on conversion of D-glutamate to L-glutamate at pH 8.0 by HPLCMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase 2/G1/S-specific cyclin-E1(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM7619(2,4-bis anilino pyrimidine deriv. 15 | 2-[(2,5-dic...)
Affinity DataIC50:  700nMAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM7616(2,4-bis anilino pyrimidine deriv. 12 | 2-N-{4-[3-(...)
Affinity DataIC50:  700nMAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM7602(4,6-bis anilino pyrimidine deriv. 15 | 4-N-(2,5-di...)
Affinity DataIC50:  800nMpH: 7.0 T: 2°CAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM7615(2,4-bis anilino pyrimidine deriv. 11 | 4-N-(2,5-di...)
Affinity DataIC50:  800nMAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM7624(2,4-bis anilino pyrimidine deriv. 20 | 2-N-{4-[3-(...)
Affinity DataIC50:  800nMAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate racemase(Enterococcus faecalis)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50245948(2-(butylthio)-8-(4-fluorobenzyl)-4-(methylamino)pt...)
Affinity DataIC50:  900nMpH: 8.0Assay Description:Inhibition of Enterococcus faecalis murI assessed as effect on conversion of D-glutamate to L-glutamate at pH 8.0 by HPLCMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM7612(2,4-bis anilino pyrimidine deriv. 8 | 4-N-(4-chlor...)
Affinity DataIC50:  1.00E+3nMAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM7606(2,4-bis anilino pyrimidine deriv. 2 | 2-N-{4-[3-(d...)
Affinity DataIC50:  1.00E+3nMpH: 7.0 T: 2°CAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase 2/G1/S-specific cyclin-E1(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM7618(2,4-bis anilino pyrimidine deriv. 14 | 2-N-{4-[3-(...)
Affinity DataIC50:  1.00E+3nMAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM7607(2,4-bis anilino pyrimidine deriv. 3 | 4-N-(2-chlor...)
Affinity DataIC50:  1.00E+3nMpH: 7.0 T: 2°CAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM7622(2,4-bis anilino pyrimidine deriv. 18 | 4-N-benzyl-...)
Affinity DataIC50:  1.00E+3nMAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM7597(4,6-bis anilino pyrimidine deriv. 10 | 4-N-(2,5-di...)
Affinity DataIC50:  1.00E+3nMpH: 7.0 T: 2°CAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM7608(2,4-bis anilino pyrimidine deriv. 4 | 4-N-(2-bromo...)
Affinity DataIC50:  1.00E+3nMpH: 7.0 T: 2°CAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase 2/G1/S-specific cyclin-E1(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM7600(2-[(2,5-dichlorophenyl)[6-({4-[3-(dimethylamino)-2...)
Affinity DataIC50:  1.00E+3nMAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase 2/G1/S-specific cyclin-E1(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM7615(2,4-bis anilino pyrimidine deriv. 11 | 4-N-(2,5-di...)
Affinity DataIC50:  1.00E+3nMAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
TargetGlutamate racemase(Enterococcus faecalis)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50245949(2-(butylthio)-4-(dimethylamino)-8-(4-fluorobenzyl)...)
Affinity DataIC50:  1.10E+3nMpH: 8.0Assay Description:Inhibition of Enterococcus faecalis murI assessed as effect on conversion of D-glutamate to L-glutamate at pH 8.0 by HPLCMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate racemase(Enterococcus faecalis)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50245789(4-amino-2-(butylthio)-8-(2,6-difluorobenzyl)pterid...)
Affinity DataIC50:  1.50E+3nMpH: 8.0Assay Description:Inhibition of Enterococcus faecalis murI assessed as effect on conversion of D-glutamate to L-glutamate at pH 8.0 by HPLCMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate racemase(Enterococcus faecalis)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50245788(4-amino-2-(butylthio)-8-(3,5-dimethoxybenzyl)pteri...)
Affinity DataIC50:  1.70E+3nMpH: 8.0Assay Description:Inhibition of Enterococcus faecalis murI assessed as effect on conversion of D-glutamate to L-glutamate at pH 8.0 by HPLCMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate racemase(Enterococcus faecalis)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50246530(4-amino-8-benzyl-2-(cyclopentylthio)pteridine-6,7(...)
Affinity DataIC50:  1.90E+3nMpH: 8.0Assay Description:Inhibition of Enterococcus faecalis murI assessed as effect on conversion of D-glutamate to L-glutamate at pH 8.0 by HPLCMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase 2/G1/S-specific cyclin-E1(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM7620(2,4-bis anilino pyrimidine deriv. 16 | 4-N-(2,5-di...)
Affinity DataIC50:  2.00E+3nMAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM7596(4,6-bis anilino pyrimidine deriv. 9 | 4-N-{4-[3-(d...)
Affinity DataIC50:  2.00E+3nMpH: 7.0 T: 2°CAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM7605(2,4-bis anilino pyrimidine deriv. 1 | 2-N-{4-[3-(d...)
Affinity DataIC50:  2.00E+3nMpH: 7.0 T: 2°CAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase 2/G1/S-specific cyclin-E1(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM7616(2,4-bis anilino pyrimidine deriv. 12 | 2-N-{4-[3-(...)
Affinity DataIC50:  2.00E+3nMAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM7617(2,4-bis anilino pyrimidine deriv. 13 | 4-N-(2-chlo...)
Affinity DataIC50:  2.00E+3nMAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM7605(2,4-bis anilino pyrimidine deriv. 1 | 2-N-{4-[3-(d...)
Affinity DataIC50:  2.00E+3nMpH: 7.0 T: 2°CAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM7614(2,4-bis anilino pyrimidine deriv. 10 | 2-N-{4-[3-(...)
Affinity DataIC50:  2.00E+3nMAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM7609(2,4-bis anilino pyrimidine deriv. 5 | 2-{[2-({4-[3...)
Affinity DataIC50:  2.00E+3nMpH: 7.0 T: 2°CAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM7613(2,4-bis anilino pyrimidine deriv. 9 | 2-N-{4-[3-(d...)
Affinity DataIC50:  2.00E+3nMAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM7611(2,4-bis anilino pyrimidine deriv. 7 | 4-N-(3-chlor...)
Affinity DataIC50:  2.00E+3nMpH: 7.0 T: 2°CAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 125 total ) | Next | Last >>
Jump to: